Search

everythinglearnresearchcommunity

for

Search:↓

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Researchers developed a quick and reliable method to test for betamethasone dipropionate and calcipotriol in ointments and drugs.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Researchers developed a quick and accurate method to measure hormones in urine, confirming a baldness treatment's effectiveness without altering hormone levels.

Researchers developed a new way to measure gene activity in single hair follicles and found that a specific gene's activity changes with different amounts and times of treatment.

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

The study suggested certain immune cells might cause alopecia areata, but it was retracted.

The decision board effectively helps lupus nephritis patients in Brazil choose treatments by clearly presenting options and side effects.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Renal histology is crucial for diagnosing simultaneous SLE and IgG4RD.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Choosing the right tools is crucial for accurately measuring lupus activity and damage.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Certain cytokines may cause or be affected by immune skin diseases, suggesting possible new treatments.

Eosinophilic infiltrate is not a reliable indicator for diagnosing chronic alopecia areata.

Dermatologists vary widely in testing practices for alopecia areata, often exceeding guideline recommendations.

Blocking interferon-gamma might help treat various autoimmune diseases.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

A new method accurately detects illegal JAK inhibitors in hair loss cosmetics.

Netherton syndrome has two subtypes with shared immune traits but different allergic and immune responses, suggesting targeted treatments.

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

The case shows how hard it is to tell apart Multiple Autoimmune Syndrome from other similar autoimmune conditions, but correct diagnosis is key for treatment to work.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

A new method was developed to analyze certain hormones and drugs in human blood efficiently.

Hydroxychloroquine may cause false results in tuberculosis tests for patients with autoimmune skin diseases.

Dermal IgA deposition without symptoms is rare in Dermatitis herpetiformis risk groups.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.